https://thegbm.com/certa-therapeutics-announces-international-non-proprietary-name-for-its-first-in-class-gpr68-inhibitor-asengeprast-ft011/ Business news, opinion, reviews, interviews Mon, 16 Sep 2024 08:00:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2